Reference : Exploring therapeutic viability of a non-dopaminergic target for Parkinson’s disease
Scientific congresses, symposiums and conference proceedings : Paper published in a journal
Life sciences : Multidisciplinary, general & others
Systems Biomedicine
http://hdl.handle.net/10993/39823
Exploring therapeutic viability of a non-dopaminergic target for Parkinson’s disease
English
Ashrafi, Amer []
Buttini, Manuel [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
Garcia, Pierre [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
del Sol Mesa, Antonio [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
Glaab, Enrico mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
2016
Movement Disorders
John Wiley & Sons
31
2
S630
Yes (verified by ORBilu)
International
0885-3185
1531-8257
Hoboken
NY
20th International Congress of Parkinson's Disease and Movement Disorders
23-06-2016
[en] Parkinson's disease ; RGS4 ; drug target
Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group)
Fonds National de la Recherche - FnR
FNR5782168 > Enrico Glaab > ExPDIENT > Exploring Parkinson’s Disease Inhibitor Efficacy on a Non-dopaminergic Target > 01/12/2013 > 31/05/2016 > 2013
Researchers ; Professionals ; Students
http://hdl.handle.net/10993/39823
FnR ; FNR5782168 > Enrico Glaab > ExPDIENT > Exploring Parkinson’s Disease Inhibitor Efficacy on a Non-dopaminergic Target > 01/12/2013 > 31/05/2016 > 2013

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Limited access
ashrafi2016mds_exploring.pdfPublisher postprint44.43 kBRequest a copy

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.